全膝关节置换术后应用抗凝药物预防深静脉血栓的临床研究进展
柏正文
黄江
安帅
李征
冯明利
曹光磊
沈惠良
1. 首都医科大学宣武医院骨科, 北京,1000532. 首都医科大学宣武医院骨科, 北京,1000533. 首都医科大学宣武医院骨科, 北京,1000534. 首都医科大学宣武医院骨科, 北京,1000535. 首都医科大学宣武医院骨科, 北京,1000536. 首都医科大学宣武医院骨科, 北京,1000537. 首都医科大学宣武医院骨科, 北京,100053
摘要:Anticoagulant drugs can prevent deep vein thrombosis and related complications after total knee arthroplasty. Traditional anticoagulant drugs (unfractionated heparin, low molecular weight heparin, warfarin, etc.) take preventive effects. At present, some new oral anticoagulants (rivaroxaban, apixababan) have been widely used in clinical practice to provide patients with a safer, more convenient and effective option for the prevention of postoperative venous thrombosis. This review focuses on the advantages and disadvantages of traditional anticoagulants such as low molecular weight heparin, vitamin K antagonists, and novel oral anticoagulants rivaroxaban, apixaban. Clinical comparison of traditional anticoagulant drugs with novel oral anticoagulants is taken to provide a reference.
关键词:静脉血栓形成抗凝血酶蛋白类手术后并发症关节成形术置换综述
分类号:R687.4(骨科学(运动系疾病、矫形外科学))
资助基金:北京市优秀人才青年骨干资助项目 (2015000020124G116)
论文发表日期:2018-01-01
在线出版日期:2025-08-15(本平台首次上网日期,不代表文献的发表时间)
页数:5( 292-296 )
英文信息展开
中国骨与关节杂志

中国骨与关节杂志

CSTPCD
ISSN:2095-252X
年,卷(期):2018,7(4)
所属栏目:综述